BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 24, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

June 24, 2020

View Archived Issues
Side and top view of Epygon valve

Affluent Medical kicks off first-in-human trial of Epygon valve

French startup Affluent Medical SA has launched a European pilot study in humans of its native-like transcatheter mitral valve technology. The Epygon valve is designed to restore the normal blood flow vortex in the left side of the heart and treat left ventricle disease, particularly in so-called “functional” patients. Read More
LOBO product image

Eyeing commercialization efforts, Okami Medical scoops up $7.2M in series D financing

Okami Medical Inc., which last year gained the U.S. FDA’s nod for the LOBO vascular occlusion system, has reported the close of a series D financing totaling $7.2 million. The round was led by U.S. Venture Partners and joined by members of Okami's board and other stakeholders. Read More
Gavel-and-scales.png

SCOTUS passes on three IPR petitions for cert, but Arthrex petition still in play

The Supreme Court has declined to hear three cases that questioned the inter partes review (IPR) process for patent litigation, although the petition for cert for the Arthrex Inc. v. Smith & Nephew Inc.; Arthrocare Corp.; and the United States of America case is still pending. Should the Supreme Court pass on Arthrex, the remaining affected IPR cases will have to be relitigated at the Patent Trial and Appeal Board (PTAB), which may give those patent holders another chance to restore their patents. Read More
DNA-dollars.png

Illumina names first UK startups backed by accelerator program

LONDON – Illumina Inc. has named the first three U.K. genomics startups to be backed by its accelerator program, after expanding the scheme from the San Francisco Bay Area to its European headquarters in Cambridge, U.K. Read More
dollar-idea-lightbulb.png

Biopolymer-based heart valve startup Foldax gets $20M series D for the clinic

Startup Foldax Inc. has raised a $20 million series D round to back its development of biopolymer-based surgical and minimally invasive heart valves. Heart valves typically are either based on porcine or bovine tissues or are mechanical. Read More
Drugs-prices-biosimilars

Pandemic shines light on SNS’ inability to keep pace with all hazards

Just the name, Strategic National Stockpile (SNS), evokes the image of a huge warehouse, or a series of warehouses spread across the U.S., strategically stocked with all the medical supplies, diagnostics and drugs that will be needed nationwide to respond to any health emergency brought on by terrorists, nuclear attacks, pandemics or other public health hazards. The reality is so much more – and so much less. Read More

Appointments and advancements for June 24, 2020

New hires and promotions in the med-tech industry, including: Clarify Medical, Dih, Fast Biomedical, Sera Prognostics. Read More

Financings for June 24, 2020

Med-tech firms raising money in public or private financings, including: Avinger, Biosig Technologies, Subiomed, Tela Bio. Read More

In the clinic for June 24, 2020

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Interrad Medical, Neurosigma. Read More

Other news to note for June 24, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Avacta Group, Biocept, Caremindr, Cortechs, Cytiva, Docbot, Erba Mannheim, Fluidigm, Global Wholehealth Partners, Incontext.ai, Integrated Genetics, Life Image, PCORI, RapidAI, Senzime, Smiths Medical, Subtle Medical, Sugarmate, Tandem Diabetes Care, Windtree Therapeutics. Read More

Regulatory actions for June 24, 2020

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Gencurix. Read More

Regulatory front for June 24, 2020

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Advamed, Kbmo Diagnostics. Read More

BioWorld MedTech’s Orthopedics Extra for June 24, 2020

Keeping you up to date on recent developments in orthopedics, including: Nuclear softening allows cells to move into dense tissue, encouraging injury repair; 3D X-ray reveals secrets from inside bones; Fantastic muscle proteins and where to find them. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 22, 2026.
  • Acid alpha-glucosidase molecular structure isolated on black

    ‘Detargeted’ targeted gene therapy improves activity in Pompe

    BioWorld
    A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
  • Roche reports new TREM2 agonists

    BioWorld Science
    F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
  • Genescience presents STAT6 degrader for atopic dermatitis

    BioWorld Science
    Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
  • Recludix’s first-in-class STAT6 inhibitor shows efficacy in atopic dermatitis

    BioWorld Science
    Researchers from Recludix Pharma Inc. reported preclinical efficacy data on REX-8756 (SAR-448755), a first-in-class orthosteric STAT6 inhibitor in models of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing